Related references
Note: Only part of the references are listed.A Radical Approach to Anionic Chemistry: Synthesis of Ketones, Alcohols, and Amines
Shengyang Ni et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Molecular tuning of farnesoid X receptor partial agonism
Daniel Merk et al.
NATURE COMMUNICATIONS (2019)
Quaternary Centers by Nickel-Catalyzed Cross-Coupling of Tertiary Carboxylic Acids and (Hetero)Aryl Zinc Reagents
Tie-Gen Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
Preeti Pathak et al.
HEPATOLOGY (2018)
INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed nonalcoholic steatohepatitis
Jonathan D. Roth et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Decarboxylative Alkynylation
Joel M. Smith et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Alkyl-(Hetero)Aryl Bond Formation via Decarboxylative Cross-Coupling: A Systematic Analysis
Frederik Sandfort et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Recent Progress on Bile Acid Receptor Modulators for Treatment of Metabolic Diseases
Yanping Xu
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Redox-Active Esters in Fe-Catalyzed C-C Coupling
Fumihiko Toriyama et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Gideon M. Hirschfield et al.
GASTROENTEROLOGY (2015)
Discovery of 6-(4-{[5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1H-indole-3-carboxylic Acid: A Novel FXR Agonist for the Treatment of Dyslipidemia
Michael J. Genin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
Sungsoon Fang et al.
NATURE MEDICINE (2015)
Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands
Andrea Carotti et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Knocking on FXR's Door: The Hammerhead-Structure Series of FXR Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities
Christian Gege et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
G-Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5) Agonists Reduce the Production of Proinflammatory Cytokines and Stabilize the Alternative Macrophage Phenotype
Klemens Hoegenauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis
Shinobu Miyazaki-Anzai et al.
PLOS ONE (2014)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
Masahiko Matsumoto et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
Rachel H. McMahan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism
Lihua Jin et al.
NATURE COMMUNICATIONS (2013)
Patented TGR5 modulators: a review (2006-present)
Antimo Gioiello et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Design, Synthesis, and Antidiabetic Activity of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide Derivatives as Potent and Orally Efficacious TGR5 Agonists
Hongliang Duan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2010)
Nonlinear least-squares data fitting in Excel spreadsheets
Gerdi Kemmer et al.
NATURE PROTOCOLS (2010)
The liver and the waistline: Fifty years of growth
Geoffrey C. Farrell
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Verena Keitel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064
Adwoa Akwabi-Ameyaw et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy
Tao Jiang et al.
DIABETES (2007)
Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
Takaharu Maruyama et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
Galya Vassileva et al.
BIOCHEMICAL JOURNAL (2006)
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
M Watanabe et al.
NATURE (2006)
Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1
S Katsuma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR
M Downes et al.
MOLECULAR CELL (2003)
Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries
KC Nicolaou et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2003)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Identification of a chemical tool for the orphan nuclear receptor FXR
PR Maloney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
TT Lu et al.
MOLECULAR CELL (2000)
Share Paper
